Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$GDHG News: Golden Heaven Group Holdings Ltd. Announces Guest Visits Increased During the 2024 Chinese Spring Festival Holiday
https://finance.yahoo.com/news/golden-heaven-group-holdings-ltd-130000542.html
$NRXP News: NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Marks a major step in the development of what could be the first drug approved for Suicidal Bipolar Depression
The study database is being cleaned and locked; statistical analysis and top-line data to follow shortly thereafter
Study maintained 95% concordance rate between study sites and central raters on primary endpoint. No unexpected Serious Adverse Events were reported.
Positive data and FDA comment would trigger the next $4 million milestone payment from partners Alvogen and Lotus and their assumption of development costs; agreement provides for up to $329 million in milestone payments and a royalty on Net Sales in the mid-teens
RADNOR, Pa., March 4, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that the 74th and last evaluable patient has completed their day 42 visit in its Phase 2b/3 study of NRX-101, the Company's patented combination of the NMDA antagonist D-cycloserine and lurasidone, in Suicidal Treatment Resistant Bipolar Depression. The database is being cleaned, finalized, and locked; statistical analysis will then be performed, with top-line data to follow shortly thereafter. As previously disclosed, positive data from this trial triggers a milestone payment from Alvogen. Alvogen will then be responsible for further development and commercialization costs for this program.
NRX-101 has been awarded Breakthrough Therapy Designation, Fast Track Designation, a Biomarker Letter of Support, and a Special Protocol Agreement by the FDA for treatment of suicidal bipolar depression. It is the only oral medication to have demonstrated reduced suicidal ideation in patients with bipolar depression, a lethal disease that claims the lives of one in five who live with it.
"This is the first clinical trial, to the company's knowledge, conducted among patients with suicidal bipolar depression in the outpatient setting. Our previous trial measured the ability of NRX-101 to maintain the anti-depressant and anti-suicidal effect of ketamine administered in the hospital setting. These patients, whose clinical need is urgent and extraordinary have routinely been excluded from the clinical trials of all previously-known anti-depressant drugs. said Dr. Jonathan Javitt, Founder, Chairman and Chief Scientist of NRx Pharmaceuticals. Although there were patients whose depression worsened and required hospitalization (we don't yet know whether they were on NRX-101 or comparator), patient safety was maintained, and no trial participant suffered a serious unexpected adverse outcome. Our thanks go out to our investigators, clinics, partners and, most importantly, our amazing patients and their families for seeing this study through to this important milestone," "
The Phase 2b/3 trial (www.clinicaltrials.gov NCT 03395392) is a randomized, prospective, multicenter, double-blind study comparing NRX-101 to lurasidone over six weeks. The Principal Investigator is Prof. Andrew Nierenberg of Harvard Massachusetts General Hospital. The primary efficacy endpoint is reduction in depression as measured on the MADRS scale and the secondary endpoint is reduction of suicidal ideation as measured by the Clinical Global Impression Suicidality Scale (CGI-SS). As previously disclosed, treatment compliance and concordance of local raters to central raters scores was in excess of 94%, well above the industry standard that is normally seen in CNS trials.
Top-line results are expected around the end of this quarter.
About NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx has partnered with Alvogen and Lotus around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently announced plans to submit a New Drug Application for HTX-100 (IV ketamine), through Hope Therapeutics, in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
About HOPE Therapeutics, Inc.
HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a Specialty Pharmaceutical Company, wholly-owned by NRX Pharmaceuticals focused on development and marketing of an FDA-approved form of intravenous ketamine for the treatment of acute suicidality and depression together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.
Notice Regarding Forward-Looking Statements
The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.
https://c212.net/c/img/favicon.png?sn=CL51263&sd=2024-03-04 View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaq-nrxp-announces-last-patient-last-visit-in-its-phase-2b3-trial-of-nrx-101-in-suicidal-treatment-resistant-bipolar-depression-302078041.html
SOURCE NRx Pharmaceuticals, Inc.
$GDHG: Golden Heaven Group Holdings Ltd. Releases 2024 Chairman's Letter to Shareholders
https://finance.yahoo.com/news/golden-heaven-group-holdings-ltd-130000724.html
About Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd. manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. With approximately 426,560 square meters of land in the aggregate, these parks are located in geographically diverse markets across the south of China and collectively offer approximately 139 rides and attractions. Due to the geographical locations of the parks and the ease of travel, the parks are easily accessible to an aggregate population of approximately 21 million people. Since September 30, 2023, Mangshi Jinsheng Amusement Park, which is one of the six parks, has been temporarily closed. The parks provide a wide range of exciting and entertaining experiences, including thrilling rides, family-friendly attractions, water attractions, gourmet festivals, circus performances, and high-tech facilities. For more information, please visit the Company's website at https://ir.jsyoule.com/.
$GEMZ News: GEMXX Corporation Forecasts Soaring Growth in India’s Colored Gemstones and Gold Markets
LAS VEGAS, Jan. 31, 2024 (GLOBE NEWSWIRE) -- via IBN -- GEMXX Corporation ( OTC: GEMZ ) ("GEMXX" or the "Company"), a leading provider of exquisite gemstone jewelry, is excited to announce its insights into the burgeoning jewelry market in India, showcasing remarkable growth projections between 2023 and 2033.
According to recent industry forecasts, the jewelry market in India is poised for exceptional expansion, with an estimated increase of USD 21.54 billion anticipated between 2023 and 2027. This surge is supported by an impressive compound annual growth rate (CAGR) of 5.54%, positioning India as a key player in the global jewelry arena.
In specific focus, the colored gemstones market in India is expected to reach US$ 707.8 million in 2024, with a robust 10.5% CAGR projected between 2023 and 2033. This acceleration is anticipated to culminate in a staggering US$ 1.9 billion for the market by 2033.
“This industry forecast pinpointing the increase in demand for colored gemstones and gold allows investors a safe haven for investing in a company backed by gemstones and gold rather than a sometimes-volatile technology stock,” stated Jay Maull, CEO of GEMXX Corp.
"The growth rate of the colored gemstone market in India is surpassing the overall growth rate of the jewelry market in India by 2.1%. Ammolite, a relatively recent addition to the Indian colored gemstone market, has the potential to attract a significant portion of buyers seeking something innovative or distinct from conventional colored gemstones," further commented Jay Maull, CEO of GEMXX Corp.
Beyond mere aesthetics, gemstones and gold in India hold a distinct significance for a substantial portion of the population, believed to possess divine powers. The demand for colored gemstones is also on the rise, driven by their perceived Vedic properties, making them more than just precious stones but also carriers of sentimental and astrological value.
GEMXX Corporation is strategically positioned to capitalize on this growing trend, offering an extensive range of ammolite products to cater to the evolving preferences of the Indian market. As a global leader in the industry, GEMXX Corp continues to innovate and provide unique gemstone options that resonate with the cultural and spiritual sentiments of consumers.
ABOUT GEMXX CORPORATION
GEMXX Corporation (OTC: GEMZ; $GEMZ) is a publicly traded, mine-to-market gold, gemstone and jewelry producer with global reach that owns mining resources, production facilities and operating assets. GEMXX controls each stage of its production including gold mining, gemstone production, jewelry manufacturing and global distribution.
GEMXX is a leading producer of top-quality finished ammolite and ammolite jewelry. The Company’s world-class gemstone cutters and jewelry designers are continuously leading the ammolite industry in new and exciting directions. Our management team is made up of the industry's leading experts with a combined total of 160 years of ammolite gemstone and jewelry business experience.
For more information, please visit: GEMXX Corporation
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our Company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Signed. /S/ Jay Maull, CEO
GEMXX Corporation
For more information, please contact:
Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
https://www.globenewswire.com/newsroom/ti?nf=OTAyOTI4MCM2MDQ4NjMwIzUwMDExNzcxNw==
https://ml.globenewswire.com/media/Yzc1ZTRhYjMtOGQ3ZS00ZmRmLWE5NWEtZDdmZWE3ZDQxZmFjLTUwMDExNzcxNw==/tiny/GEMXX-Corporation.png
Source: GEMXX Corporation
$SRM Entertainment Showcases New Products at the 2024 Las Vegas Winter Market Gift Show
January 28th - February 1st Showroom C972, C975
JUPITER, FL, Jan. 29, 2024 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc., (Nasdaq: SRM) (the “Company” or “SRM”) will introduce a new line of products at the iconic Winter Market 2024 in Las Vegas from January 28 through February 1st, featuring our new Zoo Animals assortment, Sealife assortment and custom designs.
The SRM Design Team’s creativity will be featured as we showcase our custom design capabilites and introduce our new Zoo Animals and Sealife poduct assortment lines at the Las Vegas Market Winter Show, a leading industry trade show (Showroom C972 & C975).
"The Las Vegas Market is the perfect West Coast venue to feature the creativity and experience of the SRM Team" said Rich Miller, CEO of SRM Entertainment. “We’re excited to showcase new products and design innovations that feature SRM’s imaginitive capabilities for 2024 and beyond.”
About SRM Entertainment, Inc.
SRM Entertainment, Inc. designs, develops and manufactures custom toys and souvenirs for the world's largest theme parks and entertainment venues. The Company provides exclusive custom products that are available worldwide at venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld and other attractions. Additionally, SRM recently launched its retail product line which includes patented SMURFS Sip with Me cups.
Caution Regarding Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. These statements are subject to uncertainties and risks including, but not limited to, the risk factors discussed in the “Risk Factors” section of the registration statement for the Offering filed with the SEC. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the SEC. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law.
Media and Investor Relations
Info@SRMentertainment.com
(407)-230-8100
website: SRMentertainment.com
https://www.globenewswire.com/newsroom/ti?nf=OTAyNjY3NyM2MDQxNDA0IzUwMDExODAxNA==
https://ml.globenewswire.com/media/ZTQzZTQ4ZTQtN2U3NS00MTE4LWFiODUtZTRmNzg3ZjIzNWU2LTUwMDExODAxNA==/tiny/SRM-Entertainment-Inc-.png
Source: SRM Entertainment, Inc.
$RWGI News: Rodedawg Intl. Ind, Inc. (OTC: RWGI) Acquires and Initiates New California Cannabis Distributor License
COSTA MESA, CA , Jan. 24, 2024 (GLOBE NEWSWIRE) -- Rodedawg International Industries, Inc. (OTC: RWGI) proudly announces the Company, through our wholly owned subsidiary, Parabola Mgmt. LLC, has acquired a new California cannabis distributor license in Coachella, California. Chris Swartz, CEO, states “We are proud to inform our shareholders that since the completion of the acquisition of Parabola Mgmt., LLC we have already started the acquisition and expansion of our cannabis license portfolio. We are especially proud to make this announcement as this is a first quarter 2024 milestone that has happened within the timeline of the Company roadmap. As we had previously stated, the acquisition of Parabola Mgmt. LLC included options to purchase additional licenses, we have moved quickly to complete the first purchase and we will continue moving quickly toward expanding the revenues of the Company. We are confident that our strategically planned acquisitions and merger strategy for 2024 will increase 2024 revenues to meeting and potentially exceeding our stated goal of 7 million annually”.
Mr. Swartz concludes, This is one of the many regular updates our shareholders can expect as we complete our 2024 roadmap milestones during this 1st Quarter 2024 that will lead to the significant increases to revenue growth. Once again, we continue to thank our loyal shareholders for their ongoing support as we create Rodedawg to becoming an industry leader in the licensed cannabis market.”
About Rodedawg International Industries, Inc.
Rodedawg International Industries, Inc. (OTC: RWGI) is focused on providing management services, acquisitions and restructuring resources throughout the regulated California cannabis market. We are a trusted partner and asset to licensed cultivation, distributors, manufacturers, and retail dispensaries.
Please note the company Twitter address is https://twitter.com/RWGImerger for regular updates.
About Budding Horizon, LLC
Budding Horizon, LLC is a California Limited Liability Company with offices in Orange County, California. The company is focused to providing management services for the licensed cannabis industry and seeks to leverage its expertise in the real estate acquisitions to acquire and develop a portfolio of assets.
The company website is https://buddinghorizon.com/
About Brother Buds™
Brother Buds is a cannabis delivery service based in Costa Mesa, California. During the month of July 2023, the Rodedawg will operate Brother Buds under a non-storefront cannabis delivery license. The cannabis delivery service will focus on Los Angeles County, Orange County, and norther San Diego County in the demographic area of 23.86 million in 2019. The company is focused to providing management services for the licensed cannabis industry and seeks to leverage its expertise in the real estate acquisitions to acquire and develop a portfolio of assets.
The company website is https://BrotherBuds.com
Make sure to follow us at https://twitter.com/BrotherBudsOC
Safe Harbor Statement: In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
SOURCE: Rodedawg International Industries, Inc.
$CBDW 1606 Corp. Signs Second Major ISO Partnership with CannaSite, a Top CBD Web Developer to Market AI Merchandising Chatbots by 1606. https://finance.yahoo.com/news/1606-corp-signs-second-major-130000797.html
$RWGI - Rodedawg Intl. Ind, Inc. Provides Shareholder Update - Management Releases Corporate Roadmap of Revenues and Acquisitions. https://buff.ly/3RUoF9e #Marijuana #WeedLife #WeedCommunity #Cannabis #OTC #StockMarket #StocksToWatch #StockWatchlist
$RWGI - Rodedawg Intl. Ind, Inc. Provides Shareholder Update - Management Releases Corporate Roadmap of Revenues and Acquisitions. https://t.co/BJylp4VLKa #Marijuana #WeedLife #WeedCommunity #Cannabis #OTC #StockMarket #StocksToWatch #StockWatchlist pic.twitter.com/YAz99Dg2pL
— Rodedawg International Industries Inc (@RWGImerger) January 17, 2024
$SRM Sponsors the Licensing International and Women In Toys Licensing & Entertainment Holiday Party https://www.marketwatch.com/press-release/srm-sponsors-the-licensing-international-and-women-in-toys-licensing-entertainment-holiday-party-efc17dd5?mod=mw_quote_news_seemore
$RNXT: RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
This study will be the Second Clinical Trial Evaluating RenovoGem™, a Combination Drug-Device Product, in a Difficult-to-Access Solid Tumor Cancer
December 21, 2023 08:30 AM Eastern Standard Time
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced the expansion of their clinical development pipeline in preparation for the commencement of a second Phase III trial. The CouGar Trial will evaluate RenovoGem in bile duct cancer, specifically unresectable locally advanced extrahepatic cholangiocarcinoma (eCCA).
“Unfortunately, bile duct cancer today has a poor prognosis for patients. Despite early diagnosis, the five-year survival rate is approximately 24%”
“We are pleased to engage our first clinical site for our second pivotal clinical trial. The CouGar Trial marks an important milestone for RenovoRx as we expand our clinical pipeline for RenovoGem into bile duct cancer, a difficult-to-treat solid tumor cancer,” said Leesa Gentry, Senior Vice President of Clinical Operations at RenovoRx. “I’m extremely proud of our team and our collaborators for their tremendous work reinforcing our mission to improve patient lives by delivering innovative therapies that can potentially change the current paradigm of cancer care.”
The pivotal Phase III CouGar study is a randomized study designed to evaluate the safety and efficacy of unresectable, locally advanced eCCA using intravenous cisplatin, gemcitabine, and durvalumab (all forms of chemotherapy) versus Trans-Arterial Micro-Perfusion via RenovoGem (delivery system and gemcitabine) with intravenous durvalumab. Oklahoma University (OU) Health is the first clinical site for the CouGar study.
“Unfortunately, bile duct cancer today has a poor prognosis for patients. Despite early diagnosis, the five-year survival rate is approximately 24%,” said Paula Novelli, MD FSIR, CouGar National Principal Investigator, and Associate Professor of Radiology and Director of Interventional Radiology Research at the University of Pittsburgh Medical Center. “There are currently limited treatment options for patients diagnosed with this aggressive cancer, which only prolongs life by a few months. The CouGar study brings hope for a new treatment option. RenovoGem has the potential to meet the urgent clinical need for a safe and effective therapy in this important patient population.”
Dr. David Geller, Director, UPMC Liver Cancer Center, Richard L. Simmons Professor of Surgery, University of Pittsburgh School of Medicine is the CouGar study’s Co-Investigator.
“The current standard of care for bile duct cancer is systemic (intravenous) chemotherapy, which has poor uptake and delivery since there are few blood vessels feeding this type of tumor,” said Dr. Hassan Hatoum, Principal Investigator, Associate Professor and Hematologist and Oncologist at Oklahoma University Health Stephenson Cancer Center – Gastrointestinal Cancer Clinic. “RenovoRx’s clinical trial is evaluating targeted, trans-arterial delivery of chemotherapy that is locally directed to the tumor site. Our team looks forward to participating in the CouGar study to bring this novel therapy to patients.”
RenovoGem received FDA Orphan Drug Designation for pancreatic cancer and bile duct cancer which provides 7 years of market exclusivity upon NDA approval.
About RenovoRx, Inc.
RenovoRx is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. The Company’s proprietary Trans-Arterial Micro-Perfusion (TAMPTM) therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy’s toxicities versus systemic (intravenous (IV) therapy). RenovoRx’s unique approach to targeted treatment offers the potential for increased safety, tolerance, and improved efficacy. Our Phase III lead product candidate, RenovoGemTM, a novel oncology drug-device combination product, is being investigated under a US IND that is regulated by FDA 21 CFR 312 pathway. RenovoGem is currently being evaluated for the treatment of locally advanced pancreatic cancer (LAPC) by the Center for Drug Evaluation and Research (the drug division of FDA.)
RenovoRx is committed to transforming the lives of patients by delivering innovative solutions to change the current paradigm of cancer care. RenovoGem is currently under investigation for TAMP therapeutic delivery of gemcitabine and has not been approved for commercial sale.
For more information, visit www.renovorx.com. Follow RenovoRx on Facebook, LinkedIn, and Twitter.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, including but not limited to statements regarding our clinical trials and studies, including anticipated timing, statements regarding the potential of RenovoCath®, RenovoGemTM or TAMPTM or regarding our ongoing TIGeR-PaC Phase III clinical trial study in LAPC, statements regarding the potential for our product candidates to treat or provide clinically meaningful outcomes for certain medical conditions or diseases, and our preliminary financial results, cash position and related ability to continue as a going concern. Statements that are not purely historical are forward-looking statements. The forward-looking statements contained herein are based upon our current expectations and beliefs regarding future events, many of which, by their nature, are inherently uncertain, outside of our control and involve assumptions that may never materialize or may prove to be incorrect. These may include estimates, projections and statements relating to our research and development plans, clinical trials, therapy platform, business plans, objectives and expected operating results, which are based on current expectations and assumptions that are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied by these forward-looking statements. These statements may be identified using words such as “may,” “expects,” “plans,” “aims,” “anticipates,” “believes,” “forecasts,” “estimates,” “intends,” and “potential,” or the negative of these terms or other comparable terminology regarding RenovoRx’s expectations strategy, plans or intentions, although not all forward-looking statements contain these words. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, that could cause actual events to differ materially from those projected or indicated by such statements, including, among other things: the timing of the initiation, progress and potential results of our preclinical studies, clinical trials and our research programs; the possibility that interim results may not be predictive of the outcome of our clinical trial, which may not demonstrate sufficient safety and efficacy to support regulatory approval of our product candidate, or the regulatory authority may disagree with our interpretation of the data; research and clinical development plans and timelines, and the regulatory process for our product candidates; future potential regulatory milestones for our product candidates, including those related to current and planned clinical studies; our ability to use and expand our therapy platform to build a pipeline of product candidates; our ability to advance product candidates into, and successfully complete, clinical trials; the timing or likelihood of regulatory filings and approvals; our estimates of the number of patients who suffer from the diseases we are targeting and the number of patients that may enroll in our clinical trials; the commercialization potential of our product candidates, if approved; our ability and the potential to successfully manufacture and supply our product candidates for clinical trials and for commercial use, if approved; future strategic arrangements and/or collaborations and the potential benefits of such arrangements; our estimates regarding expenses, future revenue, capital requirements and needs for additional financing and our ability to obtain additional capital; the sufficiency of our existing cash and cash equivalents to fund our future operating expenses and capital expenditure requirements; our ability to retain the continued service of our key personnel and to identify, hire and retain additional qualified personnel; the implementation of our strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights, including our therapy platform, product candidates and research programs; our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately; the pricing, coverage and reimbursement of our product candidates, if approved; developments relating to our competitors and our industry, including competing product candidates and therapies; negative impacts of the ongoing COVID-19 pandemic on our operations; our ability to comply with the continued listing standards of Nasdaq Stock Market LLC (“Nasdaq”) or the continued listing of our securities on Nasdaq; and other risks. Information regarding the foregoing and additional risks may be found in the section entitled “Risk Factors” in documents that we file from time to time with the Securities and Exchange Commission.
Forward-looking statements included herein are made as of the date hereof, and RenovoRx does not undertake any obligation to update publicly such forward-looking statements to reflect subsequent events or circumstances, except as required by law.
Contacts
Investor Contact:
KCSA Strategic Communications
Valter Pinto or Jack Perkins
T:212-896-1254
renovorx@kcsa.com
Media Contact:
Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com
https://www.businesswire.com/news/home/20231221037143/en/RenovoRx-Engages-Oklahoma-University-OU-Health-as-First-Clinical-Site-in-Preparation-for-the-Pivotal-Phase-III-CouGar-Clinical-Trial-in-Bile-Duct-Cancer?utm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork
$EVKRF: Grid Battery Metals Inc. Featured on The Investing News Network "As the supply crunch for EV battery metals intensifies, car manufacturers are increasingly taking charge of their own supply chain" Check out the full article below.
https://investingnews.com/getting-ahead-in-the-electric-vehicle-race/
Grid Battery Metals Inc. Featured on The Investing News Network
— Grid Battery Metals Inc (@GRIDBattery) November 30, 2023
"As the supply crunch for EV battery metals intensifies, car manufacturers are increasingly taking charge of their own supply chain"
Check out the full article below.$CELL $EVKRF https://t.co/LUFi1Ia37l
$SITS: Southern ITS International, Inc. Subsidiary, Pure Oil & Gas, Inc., Reports on Oil Production Numbers and Announces a New 4-Well Drilling Project in Texas
Palm Desert, California, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Southern ITS International, Inc. (Pink Open Market: SITS) proudly announces a significant achievement for its subsidiary, Pure Oil & Gas, Inc., as it began sales of oil produced by one of its wells in Texas. Production in October yielded three loads of oil—510 barrels—which has been collected and sold to BML Inc.
This success sets the stage for Pure Oil & Gas, Inc.’s next venture – a four-well drilling project in Texas.
The first new well is scheduled to begin drilling in the first week of December 2023, with production anticipated to commence within four weeks of the start of drilling operations. Funding for this new project has been secured.
Jeremy Larsen, President of Pure Oil & Gas, Inc. stated, “We are thrilled to announce our successful entry into the Texas oil reserves and look forward to the promising opportunities that lie ahead with our upcoming four-well drilling project. Our strategic location in Texas provides us with a valuable resource base, and we are confident that our collaboration with ICS Energy will contribute to the efficiency and success of our drilling operations.”
Pure Oil & Gas, Inc. has partnered with ICS Energy, LLC, an experienced driller-operator with extensive expertise in the regional geological landscape. This collaboration aims to optimize operations and bolster Pure Oil & Gas's position in the energy sector.
About Pure Oil & Gas, Inc.
Pure Oil & Gas, Inc. focuses on leveraged oil and gas acquisitions as a key strategy for growth and establishing a strong position in the industry. Supported by its parent company, Southern ITS International, Inc., Pure Oil & Gas leverages financial flexibility provided by its parent to acquire leases, producing wells, oil services companies, and new oil industry technology.
About Southern ITS International, Inc.
Southern ITS International, Inc., through its subsidiary companies, currently has operations focused on a wide variety of fields, including oil and gas exploration and development, clothing, and e-commerce fulfillment. We intend to expand upon our current base of operational companies and to increase our ownership and/or control of a portfolio of highly successful businesses. As a holding company, Southern ITS International continues to be in the market to acquire a stake in various companies, both public and private, which will complement its current operations. Our mission includes establishing a robust Direct-to-Consumer (DTC) and Business-To-Business (B2B) network, harnessing the potential of e-commerce across an array of diverse sectors, including manufacturing, distribution, and product sales. We have put in place an experienced management team that is continuing to build a diverse portfolio, buying entire companies, or interests therein, involved in technology, oil and gas, manufacturing, real estate, and other sectors, which will then become operating subsidiaries of Southern ITS International.
Precautionary and Forward-Looking Statement
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may" "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude or risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of several factors, and other risks identified in the Company's disclosures or filings with the SEC or OTC Markets, Inc. You are further cautioned that penny stocks and stocks of smaller companies like Southern ITS International, Inc. are inherently volatile and risky, and that no investor should buy this stock unless they can afford the loss of their entire investment
$LLLI: Lamperd Less Lethal Welcomes Talented New Sales Representatives to Directly Market Advanced Riot Control and Other Crisis Response Products
Source: https://www.facebook.com/lamperdlesslethal
SARNIA, ON / November 27, 2023 -- Lamperd Less Lethal, Inc. (OTC PINK:LLLI), an innovation leader and manufacturer of advanced security solutions for law enforcement, military and security agencies worldwide, has added two new Sales Representatives who are experienced and well versed in modern marketing techniques. These new additions to the Lamperd team will be making direct marketing efforts to raise awareness and close sales on the company’s full product line of advanced less lethal products which are optimized for effectiveness and safety in applications for riot control and other crisis response situations.
Maria Edison holds an Honors Bachelor of Commerce Degree from McMaster University. She served as a Market Analyst as well as a Media and Communications Resident for multiple international clients. Ms. Edison has sales experience on multicultural teams, supporting business-to-business and business-to-consumer sales efforts. She is multi-lingual utilizing English, French, Russian and Mandarin Chinese language skills to provide personalized service to a range of international clients.
Daniel Almeida holds an Honors Bachelor of Philosophy Degree from McMaster University. He served as President of the McMaster University Shooting Sports Club, where he secured sponsorships and organized shooting events for 100+ club members. An avid shooter, Mr. Almeida competes in shooting competitions in South Ontario and sells firearms from his personal collection. His experience and expertise in the field of firearms and shooting provides an excellent correlation to the Lamperd product line.
CEO Barry Lamperd stated, “With the rising need for effective security solutions we continue to see today in response to crisis situations of every kind, Lamperd certainly can use the direct sales and marketing contributions of Maria Edison and Daniel Almeida at this time. Both of these new Sales Representatives will be raising awareness in the security products market place about the wide range of solutions that the Lamperd Less Lethal line offers, with special emphasis on our company’s advantages of highest quality, versatility, effectiveness and safety. I am looking forward to working closely with both Maria and Daniel as they begin their efforts to reach out to security products customers on all levels with the aim of closing new sales in the most efficient way for everyone involved.”
About Lamperd Less Lethal:
Lamperd Less Lethal, Inc. (LLLI) is a developer, manufacturer and international sales company for advanced less lethal weapons, ammunition and other security products marketed to police, correctional, military and private security forces. The company manufactures and sells over 300 different products including small & large caliber projectile guns, flash-bang devices, pepper spray devices, 12 Gauge, 37mm & 40mm launching systems and a variety of different riot shields. Lamperd also offers advisory services and hands-on training classes run by highly accredited instructors. For more information visit: http://www.lamperdlesslethal.com
This press release contains forward-looking statements relating to Lamperd Less Lethal, Inc. Lamperd Less Lethal, Inc. undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public
the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Contact: Lamperd Less Lethal, Inc.
Barry Lamperd, President & CEO
(519) 344-4445
Email: info@lamperdlesslethal.com or sales@lamperdlesslethal.com
Company Website: http://www.lamperdlesslethal.com
Lamperd Less Lethal on Facebook: https://www.facebook.com/lamperdlesslethal
Lamperd Less Lethal on Twitter: https://www.twitter.com/LLLI_LessLethal
Barry Lamperd on Twitter: https://www.twitter.com/lamperd_llli
what are your thoughts on RAKR and TTNN
$BLFR News: BlueFire Equipment Corp (BLFR) Acquires Screaming Eagle Partners, LLC, a Cashflow Positive Family-Owned Oil & Gas Company in Texas
Woodlands, TX., Oct. 19, 2023 (GLOBE NEWSWIRE) -- BlueFire Equipment Corp. (OTC: BLFR) ("BLFR" or the "Company"), a specialist in emerging industry acquisitions, announces the 90% acquisition of Screaming Eagle Partners, LLC ("Screaming Eagle"), a cashflow positive family-owned oil and gas company in the state of Texas.
Who is Screaming Eagle:
Screaming Eagle holds a 90% ownership interest in Screaming Eagle BNR JV, LLC. (the "JV") formed in the year 2022 along with Buffalo XXII Operating, LLC. that holds the remaining 10% interest. The JV owns existing wells purchased from prior operators in the Fort Trinidad field with stacked pay zones near Madisonville TX which produces 5,950 barrels of oil/month and 17,800 MCF/month in natural gas. The JV will increase production during the next six months by executing a three well horizontal sidetrack drilling program and an eleven well workover program on existing wells.
July 1, 2023, Reserve Study of Assets:
Reserve Category Net Oil Reserves Bbls1 Net Gas Reserves Mcf2 Future Net Income $ Present Value on FNI3 disc@10% $
Proved Producing 242,920 1,599,500 11,060,470 7,243,080
Proved Non-Producing 298,730 2,508,850 17,306,490 10,792,280
Probable Undeveloped 1,878,000 0 113,974,190 78,521,280
Total All Reserves 2,419,650 4,108,350 142,341,150 96,556,640
1 Barrels
2 Million cubic feet
3 Future net income
Reserve Study of Assets Report
Latest YE & Q Financial Results:
During the year ended December 31, 2022, Screaming Eagle generated revenues of $3,942,707 net of royalties and taxes with a net operating income (EBITDA) of $922,495, and total assets of $8,318,039. All numbers are unaudited. During the period ended July 30, 2023, Screaming Eagle generated revenues of $2,065,219, net operating income (EBITDA) of $441,021, and total assets of $7,257,352. All numbers are unaudited.
The Transaction:
Through an all-stock transaction, the owners merged Screaming Eagle into BLFR in return for the issuance of 45,000,000 shares of Preferred Stock Series A and 810,000 shares of Preferred Stock Series B shares. Current CFO of Screaming Eagle, Matthew Goldston., has been appointed as Chief Financial Officer (CFO) and Nickolas S. Tabraue will retain his position as a Director of the Board, Interim Chief Executive Officer (CEO), Chief Compliance Officer (CCO), and Chief Investor Relations Officer (CIR). Furthermore, the appointment of Kirk Yariger as Chairman of the Board and Jonas Crafts as Directors of the Board of BLFR.
New Direction:
Screaming Eagle's Short-Term Plan
Beginning during Q4 2023 Screaming Eagle will execute a three well horizontal side track drilling program on the Bedias Creek asset and an eleven well clean out program on the Gin Creek Asset with 50% operating partner Exponent.
Screaming Eagle has over 200 drill sites identified on this property.
Screaming Eagle has over 5 stacked pay zones on this property.
Current wells were drilled on 700 acres spacing with only 40 acres being depleted in each well.
The plan is to drill horizontal slim hole sidetracks in existing vertical well bores on wells with flat decline curves in producing zones.
Expected Initial production of the first 6 wells is 800-1,200 bbls/day.
Screaming Eagle expects to acquire an additional 1,800 bbls/day in Q4 2023 through the acquisition of another blue chip producing asset in Texas with shale and Austin Chalk producing formations.
BLFR's Short-Term Plan
Engage a firm to plan and assist on working towards uplisting to the Nasdaq.
Engage a PCAOB auditor to commence company audit.
Cancel 18 million shares of the Company's Outstanding Common Stock.
Change the Company's name and stock symbol suited for its new direction.
Create an investor informative website for the Company.
Engage a branding and marketing firm for the Company's new direction upon the completion of the stock symbol and name change.
AboutBlueFire Equipment Corp. (BLFR)
BLFR is specialized in emerging industries acquisitions with an emphasis in the business in the industrial space. BLFR is currently focused on its recent acquisition, Screaming Eagle Partners, LLC., its first of many to acquire oil and gas company operating in the state of Texas.
For more information visit: https://www.buffaloxxii.com
SAFE HARBOR ACT: Forward-looking statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company's expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations or listing on an exchange -- including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will" and other similar expressions -- are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond the Company's control and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. No information in this press release should be construed in any manner whatsoever as an indication of the future performance of the Company's revenues, financial condition or stock price.
Company Contact:
Nickolas S. Tabraue
Interim CEO, Chief Compliance and Investor Relations Officer, and Director of the Board
info@BLFR.info
Phone (786) 375-7281
$VNUE News: COLLECTIVE SPORTS AGENCY JOINS VNUE'S ADVISORY BOARD
September 21, 2023 (PR Newswire)
Quenton Brown, Brian Donaldson and Victoria Vo to Advise VNUE on Creation of New Sports Division
VNUE, Inc. (OTC: VNUE), announced today that Collective Sports Agency, has joined VNUE's Advisory Board, and will be assisting the company in forming a new Sports Division.
The firm, including managing directors Quenton Brown and Brian Donaldson, with an all-star professional sports family pedigree, brings a wealth of experience in facilitating and advising some of the most elite and top-tier athletes in the sports industry, along with prominent sports family offices. The agency's involvement with VNUE was facilitated by Victoria Vo, Founder of Haute International, and VNUE CEO Zach Bair, who recognized the tremendous potential for collaboration. Vo will also serve on the company's Advisory Board.
The Collective Agency represents a select few elite high-profile athletes.
"VNUE's technology easily translates to the sporting world," said Bair. "We have always seen parallels and opportunities with sports, such as with our StageIt livestreaming platform as well as our pending metaverse project, and we are thrilled that Quenton and his firm have decided to partner with us on this exciting venture. We believe we can bring a lot of added value to the players, and help them connect with fans in new and unique ways, and at the same time, we can mutually benefit by working together with our respective brands."
"VNUE is the ideal company in the marketplace, one that we can strategically position for rapid growth within the sports and entertainment industry," said Quenton Brown. "VNUE's cutting-edge technology holds the potential to bring substantial value to companies, brands, and individuals within our extensive Collective Agency network."
Mr. Brown and Mr. Donaldson will be taking a leadership role in the formation of the Sports Division, working closely together with Bair and VNUE's executive management. They will also collaborate with Vo, who brings her expertise in elite brands, relationships, strategic capital partnerships, and global brand activation and reach to VNUE's Advisory Board. Collective Agency's responsibilities include forging deals with high-profile sports figures and other influential individuals, such as musical artists, to leverage VNUE's various platforms and generate revenue for both players and VNUE. Additionally, Collective Agency will strategically leverage the brands of sporting superstars to further enhance VNUE's profile, attract new investments, and explore potential brand partnerships with related parties.
Vo, an influential figure in the digital landscape, is the driving force behind numerous startups and a trusted advisor to Fortune 500 companies. Her visionary strategies have pioneered many world-first metaverse campaigns. Companies exclusively seek her as their go-to strategist for global expansion. Her expertise has been pivotal in shaping success stories for startups and established corporations in the ever-evolving digital realm.
"As we embark on this exciting journey with VNUE, our goal is to merge and bridge the gap between technology and the dynamic worlds of sports and entertainment," said Vo, "Together, we will curate elite and innovative experiences that connect fans, athletes, and artists in ways that were once unimaginable, all while leveraging the power of strategic partnerships and technology to redefine the boundaries of what's possible."
Brown, Donaldson, and Vo will be involved in the creative process for introducing new games and experiences in the metaverse, some of which that will feature superstars who will engage in gameplay with everyday fans from all walks of life, as well as several other ambitious projects.
Initially, VIP experiences on StageIt will be rolled out, where fans will have the opportunity to visit with their favorite players in an intimate setting, and ask them questions in real time
About VNUE, Inc. (www.vnue.com):
VNUE, Inc. is a multi-faceted music technology company dedicated to monetizing the live music experience for artists, labels, writers, and publishers, with products such as its set.fm instant content distribution platform, exclusive license partner and "instant live" pioneer DiscLive (www.disclive.net), and protecting the rights of artists and writers with the company's Soundstr music recognition technology (MRT) (www.soundstr.com). VNUE also recently acquired StageIt (www.stageit.com), one of the oldest and most well-known ticketed livestreaming platforms. The veteran entrepreneurs, artists and songwriters behind VNUE, led by music and tech entrepreneur and recording artistZach Bair(www.zachbairmusic.com), are passionate about the future of their industry and ensuring that rights holders' value is not lost amid always-changing technology.
About Collective Agency
Collective Agency is a trailblazing boutique athlete representation agency with a unique approach to athlete empowerment. Our agency stands as a beacon of exclusivity in the sports industry, representing only a select few elite athletes. This selectivity allows us to provide an unparalleled level of personalization and dedication to each athlete we represent. We are committed to redefining athlete representation by focusing on long-term wealth and legacy building. Our innovative approach sets us apart in the industry, as we prioritize the enduring success and financial security of our athletes. Offering exclusive access to opportunities that are otherwise unavailable through traditional representation models. Our mission is to shape the future of athlete management, providing athletes with a pathway to lasting wealth and legacy.
About Haute International:
Haute International, is an exclusive and avant-garde luxury firm renowned for its expertise in brand activations, global trade, and luxury real estate. Specializing in connecting elite brands, top-tier talent, and visionary startups, Haute International excels in uniting global relationships, forming strategic partnerships, and providing exclusive growth opportunities. Beyond its role, the firm actively engages in early-phase ventures and partners with companies seeking its expertise and support, aligning with industry leaders to drive transformation and accelerate innovation. This selectivity underscores Haute International's dedication to excellence and its mission to facilitate unparalleled growth and innovation in the global marketplace.
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words "could," "believe," "anticipate," "intend," "estimate, "expect," "may," "continue," "predict," "potential," "project" and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations, and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations, or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results could differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the Company's filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
https://c212.net/c/img/favicon.png?sn=CG16805&sd=2023-09-21
View original content:https://www.prnewswire.com/news-releases/collective-sports-agency-joins-vnues-advisory-board-301935120.html
SOURCE VNUE, Inc.
Jake is OK-- just has some water surge.
$VNUE Radio Expands Its Reach to Help Those in Need
The Streaming Radio Station Benefitting Sophia's Mission To Be Hosted on TuneIn and Audacy's Digital Platforms, Reaching Over 70MM Monthly Active Users.
NEW YORK, Aug. 17, 2023 /PRNewswire/ -- VNUE, Inc's (OTC: VNUE) streaming radio station, VNUE Radio, in association with Sophia's Mission and NEWHD Media, is expanding its reach to major media platforms, TuneIn and Audacy, while turning up the heat to create job opportunities for autistic people, those with other disabilities and Veterans, by creating innovative streaming radio that is disruptive and to scale. Additionally, VNUE Radio will be available on other platforms such as Live365. Currently, VNUE Radio is available on its VNUE Radio app, available in both the Apple Store and Google Play.
VNUE understands the meaning of connection, which is a core mission of VNUE Radio, as Zach Bair CEO of VNUE and a USAF Veteran himself, explains, "Connection is not just connecting music fans with new and exciting content, as well as a carefully curated playlist of hits throughout the decades, but also by connecting disadvantaged people who ordinarily may be brushed aside with opportunities to shine and connect with listeners in a unique and meaningful way."
This major expansion of the listener base to these platforms will allow VNUE Radio to generate more sponsorship revenue, which in turn will help create more opportunities for those with disabilities, and at the same time exposes the artists of today and yesterday to millions of people around the world. Bair said it is his hope that brand partners will see this opportunity to help the cause.
With the addition of both Audacy and TuneIn, VNUE radio will have a combined reach of over 70 million people, including Canada and the UK, bringing VNUE's unique platform and message of love and acceptance to a diverse audience, and exposing new music to a new generation of listeners craving creative content.
Zach Martin, Founder of Sophia's Mission and NEWHD Media thinks that VNUE Radio compliments Sophia's objective to create meaningful employment for those with disabilities and at the same time connecting with artists and listeners in a very positive way using the latest technologies. "People are on their devices all the time and looking for ways to enjoy themselves," said Martin. "We are committed to making a connection with listeners by providing amazing entertainment while at the same time raising awareness."
Bair said, "VNUE Radio and this massive expansion compliments VNUE's other platforms such as StageIt ,Set.fm and our metaverse initiative, all of which form unique connections between fans and artists, and creates new revenue opportunities for the artists."
Listeners may currently download the VNUE Radio app from the Apple Store or Google Play and will soon be able to find the station on the Audacy platform, as well as the current availability of TuneIn and Live365. With each download and song play, listeners are helping those in need have a better life.
About VNUE, Inc. (http://www.vnue.com)
VNUE, Inc. is a multi-faceted music technology company dedicated to monetizing the live music experience for artists, labels, writers, and publishers, with products such as its set.fm instant content distribution platform, exclusive license partner and "instant live" pioneer DiscLive (www.disclive.net), and protecting the rights of artists and writers with the company's Soundstr music recognition technology (MRT) (www.soundstr.com). VNUE also recently acquired StageIt (http://www.stageit.com), one of the oldest and most well-known ticketed live-streaming platforms.
The veteran entrepreneurs, artists, and songwriters behind VNUE, led by music and tech entrepreneur and recording artist Zach Bair (http://www.zachbairmusic.com), are passionate about the future of their industry and ensuring that rights holders' value is not lost amid always-changing technology.
About NEWHD Radio (http://www.newhdmedia.com)
NEWHD Radio is the innovative radio platform founded by longtime rock radio jock Zach Martin. NEWHD's vision is to provide exciting and innovative programming to a worldwide audience using emerging radio technology, while taking advantage of low-cost lease HD signals in major markets. NEWHD, in a strategic partnership with Game On Media Solutions (www.gameonmediasolutions.com), currently operates NEWHD-NY and NEWHD-LA, with a goal of adding additional stations in South Florida, Buffalo, Nashville and various other markets throughout the US. Founder Zach Martin is a direct descendant of Zachary Taylor, the 12th president of the United States. He has been a fixture in New York radio for over three decades. He worked with legendary radio personality Scott Muni for almost a decade and has interviewed "rock royalty" ranging from Robert Plant and Ringo Starr to, in his words, "a whole bunch of country artists." NEWHD also provides unique opportunities for people in the spectrum (autism), giving people a chance to contribute and be part of something special.
Cision View original content:https://www.prnewswire.com/news-releases/vnue-radio-expands-its-reach-to-help-those-in-need-301903988.html
Both $CURR and $MMMW have encouraging new products.
$AVRW (formerly CURR) Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
New Branding Reflects Company's Commitment to the Future of Wellness
SHERMAN OAKS, CA / ACCESSWIRE / August 8, 2023 / Avenir Wellness Solutions, Inc. (OTC Pink:CURR) ("Avenir" or the "Company"), a proprietary broad platform and wellness technology company, today announced that it has received regulatory approval to officially change its ticker symbol from "CURR" to "AVRW" effective at the stock market opening on August 9, 2023. The ticker symbol change follows the corporate name change to "Avenir Wellness Solutions, Inc." in October 2022. The name change reflects the renewed focus of the Company with its incubator strategy and continuing efforts to create and commercialize wellness technologies with quality products and brands in the wellness and beauty space. In connection with the name change, the Company previously launched a new corporate website at: http://www.avenirwellness.com.
"This re-branding opened a new chapter for the Company beginning last year with strategic and deliberate changes. As we continue to focus on our short and long-term growth strategy by steadily increasing revenue with high margin products, we are also broadening our wellness platform technology using an incubator strategy to monetize its intellectual property. We fully intend to continue creating new innovative technologies supported with intellectual property to not only grow the business but grow the Company's shareholder value as well," stated Nancy Duitch, Avenir CEO.
The Company's common stock will continue to be traded on OTC Pink Market and the CUSIP number will not be changing. The Company has reapplied to move its common stock back to the OTCQB now that all delinquent filings have been filed with the U.S. Securities and Exchange Commission.
This rebranding is part of the Company's shareholder value initiatives and ongoing commitment to delivering innovative and highly desired wellness technologies to the marketplace. The Company's long-term growth strategy is to increase revenue with high margins, use its incubator strategy to grow the patent and product portfolio as well as monetize the IP patent technology through strategic partnerships. These initiatives, along with the Company's relationships with Nicole Kidman and other major social media influencers, is expected to help propel its health and beauty products to become a household name, consistent with its strategy to become a genuine house of recognizable and respected quality brands.
"Providing cutting edge products, proprietary delivery systems, and impactful marketing strategies to an enormous health and wellness industry that is desperate for new innovations and solutions is the key for us to becoming a House of Quality Brands. Rebranding the Company and delivering on our value proposition is very exciting, and it will ultimately increase shareholder value," continued CEO Nancy Duitch.
For more information, please visit: http://www.avenirwellness.com and http://www.seralabshealth.com
About Avenir Wellness Solutions, Inc.
Avenir Wellness Solutions, Inc. (OTC Pink:AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on (15) fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that will be part of its incubator strategy in order to monetize its IP. As a vertically integrated platform company, Avenir looks to partner or license its IP technology with wellness companies worldwide. For more information visit: http://www.avenirwellness.com.
About The Sera Labs, Inc.
Sera Labs, a wholly owned subsidiary of Avenir, is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting-edge technology. Sera Labs creates high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories beauty, health & wellness, Sera Labs sells products direct-to-consumer (DTC) via online website orders, including opt-in subscriptions, under private label to multi-level marketers and sold online and in-store at major national drug, grocery chains, convenience stores, and mass retailers. For more information visit: http://www.seralabshealth.com and follow Sera Labs on Facebook and Instagram at @
Investor Relations
Hanover International Inc.
T: (760) 564-7400
E: investor@avenirwellness.com
SOURCE: Avenir Wellness Solutions, Inc. (f/k/a Cure Pharmaceutical Holding Corp.)
View source version on accesswire.com:
https://www.accesswire.com/773094/Avenir-Wellness-Solutions-Announces-New-Ticker-Symbol-As-Final-Part-of-Exciting-New-Brand-Identity
$CURR News: Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year Over Year Revenue Increases and Continued High Gross Margins
New Product Showing Encouraging Early Results
SHERMAN OAKS, CA / ACCESSWIRE / July 31, 2023 / Avenir Wellness Solutions, Inc. (OTC:CURR) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the quarter ended March 31, 2023.
Key operational highlights for the first quarter included the following:
Net revenue in the first quarter of 2023 increased 15.1% year-over-year and 35.6% sequentially from Q4 2022 to $1.2 million with further increases expected in the second half of the year.
Gross margins for the first quarter improved by 102 basis points to 78.9% in 2023 compared to the same period in 2022 with expectations of continuing high margin sales with the launch of new products and marketing initiatives.
SG&A expenses (excluding non-cash charges) for the first quarter increased by $0.5 million in 2023 compared to 2022 driven by increased investment spend on advertising and promotion.
Net operating loss from continuing operations (excluding the non-cash charges) decreased by $0.5 million in 2023.
Cost reductions and operating leverage are expected to help narrow the operating loss (excluding non-cash charges) in the second half.
"We are very pleased with our results and accelerating sales in the first quarter which reflect the improving trajectory of the business. The proceeds from the July 2022 asset sale allowed us to continue to invest in the future of the Company, however, the delay in receiving the balance of the proceeds versus our expectations will have a negative impact on our second quarter. Our margin expansion initiatives continue to deliver results, and we are moving forward with our efforts to reduce SG&A expenses and to maximize operating leverage.
We are also very excited by the continued success of the advertising and marketing campaigns for DNA Complex, which is our new addition to the Seratopical Revolution family of products. DNA Complex, which boasts a proprietary delivery system technology developed for the Company by Rob Davidson and his team, has gone viral with Beauty editors praising this instant line reducer in InStyle, People, Glamour, Zoe Report, Vogue, theSkimm, ET Online and many more," said Nancy Duitch, Avenir CEO.
Operational Highlights
Other operational highlights during the first quarter of 2023 included:
The Company is focused on becoming the future of wellness and beauty with its long-term growth strategy to increase revenue with high margins by using its incubator strategy, product development and marketing and through strategic partnerships and geographic licensing deals. These initiatives, along with the Company's relationships with Nicole Kidman and other major social media influencers, have also helped propel its health and beauty brands to become household names and the Company to become a genuine house of recognizable and respected quality brands.
We have recently enhanced the reach and visibility of our Brand Ambassador, Nicole Kidman, as part of the launch of our transformational Seratopical Revolution marketing campaigns and the unveiling of our revolutionary new product, DNA Complex. The Company recently received prominent mentions of our DNA Complex along with the rest of the Seratopical Revolution line after the Oscars, the Academy of Country Music Awards and the Met Gala.
Here are some exciting examples of our positive coverage:
THE OSCARS
New Beauty March 12 "This Tightening Gel Is the Secret to Nicole Kidman's Smooth Skin"
InStyle "Nicole Kidman's Dewy Oscars Look Was Thanks to the Moisturizer Shoppers Say Makes Skin Look "Flawless""
THE ACADEMY OF COUNTRY MUSIC AWARDS
People Magazine May 11 "Nicole Kidman and Keith Urban Twin in Suits on the 2023 ACM Awards Red Carpet: See Their Looks!"
New Beauty May 11 "The Under-Eye Product Nicole Kidman Uses to Prevent Concealer Creasing"
THE MET GALA
InStyle May 2 "Nicole Kidman's Flawless Met Gala Skin Called on This Facelift in a Bottle That's Selling Fast"
Page Six May 2 "Best beauty and makeup looks of the 2023 Met Gala - and how to shop them"
Glamour May 2 "The Best Makeup Looks on the Met Gala 2023 Red Carpet"
Governance and Reporting Update
On April 19, 2023, Avenir announced the appointment of Urish Popeck & Co., LLC as its new independent registered public accounting firm. Urish Popeck has a highly respected reputation in the financial accounting industry and the decision to engage them was unanimously approved by our Board of Directors and Audit Committee. Their immediate assignment was to complete the audit of our financial statements for the fiscal year ended December 31, 2022, and on July 28, 2023, the Company filed its 2022 Annual Report on Form 10-K and its March 31, 2023 Quarterly Report on 10-Q.
For further details, please visit our website to review our most recent Form 10-K and Form 10-Q filed on July 28, 2023 at: http://www.avenirwellness.com/sec-filings/
About Avenir Wellness Solutions, Inc.
Avenir Wellness (OTC: CURR) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on (15) fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that will be part of its incubator strategy in order to monetize its IP. As a vertically integrated platform company, Avenir looks to partner or license its IP technology with wellness companies worldwide. For more information visit: www.avenirwellness.com.
About The Sera Labs, Inc.
Sera Labs, a wholly owned subsidiary of Avenir, is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting-edge technology. Sera Labs creates high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories beauty, health & wellness, Sera Labs sells products direct-to-consumer (DTC) via online website orders, including opt-in subscriptions, and under private label to multi-level marketers. Sera Labs products are also sold online and in-store at major national drug, grocery chains, convenience stores, and mass retailers. For more information visit: www.seralabshealth.com and follow Sera Labs on Facebook and Instagram at @seratopical, as well as on Twitter at @sera_labs.
The Sera Labs, Inc. ("Sera Labs"), a wholly-owned subsidiary of Avenir, is a trusted leader in the wellness and beauty sectors utilizing cutting edge technology and high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale and is strategically positioned to grow its beauty and wellness products into household brands. Sera Labs products are sold Direct to Consumer with a subscribe and save option, as well as in major national drug, grocery and mass retailers. For more information visit: Seratopicalrevolution.com, Seratopical.com, Seralabshealth.com and follow Sera Labs on Facebook and Instagram at @seratopical, as well as on Twitter at @sera_labs.
Forward Looking Statement
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.
Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.
CONTACTS:
Media
Autumn Communications
E: seratopical@autumncommunications.com
T: (212) 206-9780
Investor Relations
Hanover International Inc.
T: (760) 564-7400
E: investor@avenirwellness.com
SOURCE: Avenir Wellness Solutions, Inc. (f/k/a Cure Pharmaceutical Holding Corp.)
View source version on accesswire.com:
https://www.accesswire.com/771135/Avenir-Wellness-Solutions-Reports-First-Quarter-2023-Results-with-Strong-Sequential-and-Year-Over-Year-Revenue-Increases-and-Continued-High-Gross-Margins
$SMME: SmartMetric Sees the Interfacing of In Device Embedded AI With Intermitant Remote AI Interfacing Will Bring a Massive Leap in Data Security for Its Biometric Credit Cards
June 29, 2023 (BusinessWire)
SmartMetric, Inc. (OTC: SMME) embedding AI (artificial intelligence) in hardware that then interfaces with powerful remote AI systems will allow for a massive increase in device security.
"AI interfaced with remote AI processing will allow remote devices such as credit cards to tap into the power of AI to provide for lightening fast and complex instant processing security functions such as identifying malicious hacking intrusions along the payment continuum," said SmartMetric's President and CEO, Chaya Hendrick.
The advantage of AI as an embedded in the device, hardware-based security is that it provides a greater level of security than a remote centralized processor. A central computer or even a smartphone that is always connected to a network wirelessly, provides many opportunity points for malicious intrusion. A device such as a credit card that is not connected all the time to a network is without question far more secure. "Always connected means always hackable," said Chaya Hendrick.
"Intermittent remote processor connectivity greatly impairs opportunities for data thieves to intercept and collect data. Adding to this AI based enhanced data security with embedded on the card and interfaced intermittently with a remote central AI enhanced security platform, will provide a huge leap in card data flow security across the payment network," said Chaya Hendrick.
AI in device and centralized computing, allows for a staggering increase in variable analysis and algorithmic computations that will be able to be used for instance to detect malicous data capture attempts while at the same time providing a massively enhanced level of encryption. Especially if this encryption is paired with on device AI enhanced encryption with payments processing AI enhanced remote systems.
"Looking into the future, we are going to see amazing gains in data security. We will see almost unthinkable advances in particular when we marry AI with Quantum computing. The marriage of advanced software with advanced computing is going to change the world of data in more 'good' ways then we can imagine," said Chaya Hendrick.
"SmartMetric, while it is about to release its advanced biometric fingerprint secured and activated credit card, is working on adding embedded AI as a hardware feature inside of its intelligent biometric card platform. Providing for a quantum leap forward in both card data security and payment network data security along with its ultra secure credit card that is secured by the users' biometrics," said Chaya Hendrick.
The SmartMetric biometric fingerprint recognition technology built inside of the credit and debit card uses embedded biometric technology to positively recognize the card holder and then only after a positive fingerprint recognition, turn on the cards EMV contact and contactless payments chip.
Market research has shown that 70% of current credit card users are willing to pay $70.00 for a biometric secured credit card. The single largest motivation is wanting to feel more secure. The same research showed that nearly 70% of existing 100's of millions of credit card users would prefer to use a biometric credit card.
To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: www.smartmetric.com
Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230629355476/en/
SOURCE: SmartMetric, Inc.">
SmartMetric, Inc.
Chaya Hendrick
Tel: (702) 990-3687 Mobile: 305.607.3910 Pacific Time
ceo@smartmetric.com
http://www.smartmetric.com
$LLLI: Much Quicker Order Fulfilment Than Competitors for Less Lethal Weapons, Riot Shields and Other Vital Security Products Marketed Worldwide: Lamperd Less Lethal, Inc. (Stock Symbol: LLLI)
by ABNewswire
July 17, 2023 7:07 PM
https://www.benzinga.com/pressreleases/23/07/ab33259191/much-quicker-order-fulfilment-than-competitors-for-less-lethal-weapons-riot-shields-and-other-vi
From the article:
Developer and Manufacturer of Less Lethal Weapons for Riot Control and Related Uses by Police, Corrections, Military and Other Security Forces Worldwide.
Products Manufactured In-House with Local Raw Materials Suppliers for Much Quicker Order Fulfilment Than Competitors Who Outsource Production.
Perfect Safety Record with Zero Deaths in All Company History.
Global Non-Lethal Weapons Market Size Estimated at Over $4.9 Billion in 2023 and Expected to Reach $6.1 Billion by 2028.
Two New Orders for Humane Animal Distraction Products in Canada.
Order Received for Special Munitions Rounds from New International Customer.
Prepared to Deliver Advanced Riot Shields in a Range of Sizes and Types.
$CURR Avenir Wellness $CURR DNA Complex retails for $79.99 USD and is currently available at: https://seralabshealth.com/discount/INVESTOR20
20% Discount with Code: INVESTOR20
Learn more here: CURR CEO Nancy Duitch, discussing how she has spent her entire career working on solution-based health, wellness and beauty products to help people look and feel their best.
https://podcasts.apple.com/us/podcast/lifetime-of-health-and-wellness-nancy-duitch-ceo/id1211773564?i=1000608721227
$LLLI: The most recent announcement directly credits the company's ability to fulfill orders much quicker than competitors as an important factor in gaining new business at this time.
Lamperd Less Lethal Receives Order and Full Payment for Special Munitions Rounds from New International Customer
SARNIA, ON / May 31, 2023 / Lamperd Less Lethal, Inc. (OTC PINK:LLLI), an innovation leader and manufacturer of advanced security solutions for law enforcement, military and security agencies worldwide, has received an important police services order with full payment from a new international customer. This order is for a special type of less lethal munition which Lamperd has carefully developed in conjunction with The University of Western Ontario.
One of the reasons this customer selected Lamperd Less Lethal was the quick delivery time which we can provide. Because Lamperd performs all manufacturing in-house and also has well established local raw materials suppliers, we are able to fulfill orders in much shorter time frames than our competitors who are currently taking many months or even over a year to deliver. Lamperd can manufacture and fulfill most orders in a matter of a few weeks.
Lamperd offers a wide range of less lethal munitions for 37mm, 40 mm, 20 gauge and 12 gauge weapons so officers can have the right tool for every job. These options include our proven WASP & SOC Impact rounds as well as Muzzle Blast Pepper, including Aerial Burst, Green Sticky Gel, Door Breacher and lower capacity Training Rounds.
Lamperd’s OC Aerial Burst munitions can travel 100+ ft and cover an area of 200 sq.ft for more effective and safer riot control. These rounds drop no dangerous debris, only a powerful but harmless OC compound to disburse unruly crowds. Lamperd offers Aerial Burst options for multiple types of launching systems including 20 gauge and 12 gauge police shotguns that are in widespread use around the world.
Lamperd Less Lethal also offers a full line of Humane Animal Control Products to protect police, animal control and other officers from aggressive animals without having to resort to deadly force. Too many pets and other animals are needless killed each year but Lamperd has the solution with less lethal munitions that can scare off an aggressive dog or other animal without causing any harm. Every police department and animal control agency should have these options in use.
Lamperd Less Lethal has be best safety record in the global less lethal industry. For over 50 years there have been zero deaths and zero serious injuries resulting from the use of any Lamperd products.
See the full Lamperd Less Lethal product line and training services available at http://www.lamperdlesslethal.com.
About Lamperd Less Lethal:
Lamperd Less Lethal, Inc. (LLLI) is a developer, manufacturer and international sales company for advanced less lethal weapons, ammunition and other security products marketed to police, correctional, military and private security forces. The company manufactures and sells over 300 different products including small & large caliber projectile guns, flash-bang devices, pepper spray devices, 12 Gauge, 37mm & 40mm launching systems and a variety of different riot shields. Lamperd also offers advisory services and hands-on training classes run by highly accredited instructors. For more information visit: http://www.lamperdlesslethal.com
This press release contains forward-looking statements relating to Lamperd Less Lethal, Inc. Lamperd Less Lethal, Inc. undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results. Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Contact: Lamperd Less Lethal, Inc.
Barry Lamperd, President & CEO
(519) 344-4445
Email: info@lamperdlesslethal.com or sales@lamperdlesslethal.com
Company Website: http://www.lamperdlesslethal.com
Lamperd Less Lethal on Facebook: https://www.facebook.com/lamperdlesslethal
Lamperd Less Lethal on Twitter: https://www.twitter.com/LLLI_LessLethal
Barry Lamperd on Twitter: https://www.twitter.com/lamperd_llli
SOURCE: https://ih.advfn.com/stock-market/USOTC/lamperd-less-lethal-pk-LLLI/stock-news/91204709/current-report-filing-8-k
CHEAP--UNDERVALUED--https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172059678
$CDSG Titan Lithium Inc., (OTC Markets: CDSG) (the “Company” or “CDSG”) is pleased to announce strong Lithium geochemical sampling results from the continuation of the surface sampling program at the company’s huge Titan 1 lithium property in Tanzania.
Click here:
https://finance.yahoo.com/news/cdsg-extends-lithium-north-zone-130000322.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
$KRTL ~ KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
$KRTL ~ KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
$ASRE News: Astra Energy Inc. Announces Strategic Partnership with Phambili, USA
SAN DIEGO, June 15, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Astra Energy Inc. (OTCQB: ASRE) ("Astra" or the "Company"), is pleased to announce that the Company's subsidiary Astra Energy California Inc. ("Astra California") has finalized an agreement with Phambili, USA ("Phambili"). Phambili solidifies municipal solid waste ("MSW") and organic waste processing to a non-waste material and refinement to valuable market commodities, such as sustainable aviation fuel ("SAF").
The strategic partnership is intended to combine total waste processing utilizing Regreen Technologies Inc.'s energy pellets with the Phambili conversion unit to further refine into finished marketable commodities for global distribution. The goal of the collaboration is to apply the combined technologies to provide zero-emission, low sulfur, high Btu/Kcal value commodities to the world, including, but not limited to, sustainable aviation fuel, marine biofuels and organic pesticides.
"Our mutual objective is to process MSW and create valuable commodities from it. This will create an ongoing revenue stream from each of our global projects and drive value for our shareholders and investors," stated Douglas D. Hampton, president and CEO of Astra California.
Musa Msimango, the joint CEO of Phambili Energy stated, "We are thrilled with the collaboration that will take place between the groups, and we are hugely excited about the possibilities of making a real impact and a real difference in the global fight against GHG emissions using our combined technologies. The synergies between our two groups, as well as the manner in which each technology perfectly complements the other in a unique way, means that together we are able to achieve results that no other technology or company on the globe has yet been able to achieve. In our ability to process biomass waste in an energy neutral and carbon-negative manner, we have no doubt that together with Astra California, we will become a global influencer in the green technology industries, and we look forward to working with them. Together, we are not only able to achieve results that no other technology or company has been able to achieve yet, but also pioneer and innovate new technologies that would revolutionize the green economy."
About Phambili, USA
Phambili, USA is a subsidiary of Phambili Energy (PTY) LTD. For those seeking to rethink and discover enhanced techniques for carbon capture and sequestration ("CCS"), Phambili has developed the formula to deconstruct organic waste material, rubber and plastic into circular economy products. These products are then reassembled as input for a range of valuable GHG-emission-free transportation biofuels, green chemicals, sustainable fertilizers, biochar, activated carbons and renewable energy.
Phambili, through its patented micro-refinery process, delivers value from waste by creating carbon-negative, high-performance products for the agricultural, pharmaceutical, transportation, aviation, food, and industrial sectors in an environmentally friendly manner.
For more information on Phambili, USA, visit the company's website at www.phambiliusa.net.
About Astra Energy Inc.
Astra Energy Inc. is an integrated solutions provider investing in and developing renewable and clean energy projects in markets where demand is high, supply is limited and there is an opportunity to address other imminent market needs.
Astra's corporate strategy is rooted in securing technologies and assets; identifying viable market opportunities; and bringing together resources, expertise, technology and defined action plans to execute first-in-class projects that benefit communities, local economies, the planet and the Company's investors.
Its goal is to create a more secure and sustainable power sector that supports the Company's purpose, mission and values to transform the economic, environmental and social landscape for generations to come.
For more information on Astra Energy Inc., visit the Company's website at www.astraenergyinc.com.
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
This document contains forward-looking statements. In evaluating these forward-looking statements, readers should consider various factors, including the Company's ability to change its direction, its ability to keep pace with new technology and changing market needs, and the competitive environment of its business. These and other factors may cause the Company's actual results to differ materially from any forward-looking statement.
Corporate Communications:
Heidi Thomasen
IR@astraenergyinc.com
1-800-705-2919
Wire Service Contact
InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
Editor@InvestorWire.com
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$KRTL ~ KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$IVDN and $MMMW patented competitive technologies.
$KRTL ~ KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$KRTL ~ KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
$IVDN: Increasing Orders and Insider Share Purchase; Patented Evacuated Cell Insulation; Innovative Designs: Stock Symbol: IVDN
June 6, 2023
https://www.einpresswire.com/article/637864225/increasing-orders-and-insider-share-purchase-patented-evacuated-cell-insulation-innovative-designs-stock-symbol-ivdn
From the article:
- $IVDN has a Very Small Stock Structure of Only 36 Million OS / 16 Million Float
- Sole Maker of Patented Insultex® Insulation Delivering Energy Saving Performance Far Superior to All Competition.
- Greater Energy Savings from Insultex® Insulation Delivers Essential Benefits of Economic Gains for the User and Carbon Reduction for the Environment.
- Significant New Orders for Insultex House Wrap® from Repeat Customers.
- Insider Buying from Board Member with Lockheed Martin & NASA Background.
- New US Patent Issued for Insultex® Manufacturing Process.
- International Distributor Agreement Signed with a Minimum Order Valued at $2 Million Per Year.
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$KRTL ~ KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
UNDERVALUED->>>>>>>>>>- $2,000,000 IN CASH-https://www.nasdaq.com/press-release/spo-global-inc.-announces-strong-1st-quarter-financial-operations-and-performance
***AI***LOW-FLOAT-UNDERVALUED-PLAY -https://www.otcmarkets.com/stock/SPOM/security
$KRTL Lakewood, CO, May 30, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
https://www.stocktitan.net/news/KRTL/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-9gtfkgeffnh3.html
$KRTL ~ KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
$KRTL Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL Axiom utilized the data to complete a full-service package including data acquisition, processing, analysis, technical reporting, and claim management.
1. History repeats itself.
2. People drive buying and selling.
3. Buy at support, sell at resistance. Everyone sees the same thing and they're all just waiting to jump in the pool.
4. Short rallies not selloffs. When markets drop, shorts finally turn a profit and get ready to cover.
5. Don't buy up into a major moving average or sell down into one. See #3.
6. Don't chase momentum if you can't find the exit. Assume the market will reverse the minute you get in. If it's a long way to the door, you're in big trouble.
7. Exhaustion gaps get filled. Breakaway and continuation gaps don't. The old traders' wisdom is a lie. Trade in the direction of gap support whenever you can.
8. Trends test the point of last support/resistance. Enter here even if it hurts.
9. Trade with the TICK not against it. Don't be a hero. Go with the money flow.
10. If you have to look, it isn't there. Forget your college degree and trust your instincts.
11. Sell the second high, buy the second low. After sharp pullbacks, the first test of any high or low always runs into resistance. Look for the break on the third or fourth try.
12. The trend is your friend in the last hour. As volume cranks up at 3:00pm don't expect anyone to change the channel.
13. Avoid the open. They see YOU coming sucker 1-2-3-Drop-Up.
14. Look for downtrends to reverse after a top, two lower highs and a double bottom.
15. Bulls live above the 200 day, bears live below. Sellers eat up rallies below this key moving average line and buyers to come to the rescue above it.
16. Price has memory. What did price do the last time it hit a certain level? Chances are it will do it again.
17. Big volume kills moves. Climax blow-offs take both buyers and sellers out of the market and lead to sideways action.
18. Trends never turn on a dime. Reversals build slowly. The first sharp dip always finds buyers and the first sharp rise always finds sellers.
19. Bottoms take longer to form than tops. Fear acts more quickly than greed and causes stocks to drop from their own weight.
20. Beat the crowd in and out the door. You have to take their money before they take yours, period.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |